Compass Therapeutics to Participate in Upcoming November Investor Events
Globenewswire· 2025-11-03 21:00
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November. Details are as follows: Guggenheim 2nd Annual Healthcare Innovation ConferenceLocation: Boston, MADate: Monday, November 10, 2025 Time: 3:30 PM ETWebcast L ...
SEALSQ to Kick Off Quantum Partnership with BWT Alpine Formula One Team on November 19-21 at Las Vegas Grand Prix
Globenewswire· 2025-11-03 21:00
Geneva, Switzerland, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that BWT Alpine Formula One Team has welcomed SEALSQ as Team Partner, with the partnership commencing ahead of the 2025 Las Vegas Grand Prix this November. SEALSQ’s innovative quantum technology will bolster the team’s growing partnership portfolio and debut ...
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Second Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending January, February, and March 2026
Globenewswire· 2025-11-03 21:00
GREENWICH, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On October 24, 2025, our Board of Directors declared the following distributions on our common stock: Month EndingRecord DatePayment DateAmount Per ShareJanuary 31, ...
ICMCI Visits Leverage Consulting, Spotlights China's Strategy in Execution
Globenewswire· 2025-11-03 21:00
SHANGHAI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amid the worldwide wave of intelligent transformation across industrial chains, the strategic consulting sector is accelerating its integration with the real economy. In recent days, the International Council of Management Consulting Institutes (ICMCI) visited Leverage Consulting and toured Softide Smart Bed Super Factory, a flagship project empowered by Leverage Consulting's strategic consulting framework. Under the theme "Borderless Strategy, Symbiotic Innovatio ...
Daré Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment
Globenewswire· 2025-11-03 21:00
The project underscores Daré Bioscience’s growing role in shaping the future of contraceptive innovationSAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced a contract with the Gates Foundation under which it can receive up to approximately $300,000 to conduct a strategic landscape review of organizations with capabiliti ...
Super League Sets Third Quarter 2025 Earnings Date, November 13, 2025
Globenewswire· 2025-11-03 21:00
SANTA MONICA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), a leader in playable media trusted by global brands to reach and activate gaming audiences through playable ads and gamified content, announced today that the Company will post its third quarter 2025 financial results after market close on Thursday, November 13, 2025. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results and can be accessed using the below dial-in numbers or regis ...
Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results
Globenewswire· 2025-11-03 21:00
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, November 10, 2025, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the third quarter ended September 30, 2025. Webcast InformationDate: Monday, November 10, 202 ...
iFLYTEK AINOTE 2 Set to Sell Globally on November 1, 2025, Redefining Professional Productivity with Advanced AI
Globenewswire· 2025-11-03 20:56
HEFEI, China, Nov. 03, 2025 (GLOBE NEWSWIRE) -- iFLYTEK is thrilled to announce the global availability of the AINOTE 2, the world’s thinnest E-Ink tablet. The device, which has already broken crowdfunding records for E-Ink tablet on Kickstarter, will officially become available for purchase worldwide on November 1, 2025, with a special introductory price of just $599 USD. iFLYTEK AINOTE 2 The AINOTE 2 is not merely an upgrade. It represents a significant shift in how professionals interact with their note ...
Stellar Pictures Brings High-Profile IPs to Cannes & London, Showcasing Chinese Culture
Globenewswire· 2025-11-03 20:54
SHANGHAI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- When Eastern aesthetics embrace a global perspective, an industry dialogue spanning Shanghai and Europe is opening a new chapter for Chinese culture's global expansion. As an IP operating company focused on high-quality content, Stellar Pictures has showcased its multiple masterpieces, including Love Between Fairy and Devil, Love Game in Eastern Fantasy, Fated Master and Disciple, The Melody of Love , and The Sword, at the 2025 MIPCOM and the Shanghai-London Scree ...
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 Per Share for November 2025
Globenewswire· 2025-11-03 20:50
公司股息分配 - 公司宣布2025年11月每股派发0.08美元的月度股息 [1] - 股息将于2025年11月28日支付给普通股股东 [1] - 公司按月宣布股息 下一次股息预计在12月初宣布 [2] 股息税务特征与支付条件 - 本次股息中约20%预计为资本返还 [3] - 股息税务特征的最终确定需等待2025财年结束后 可能与当前预估有实质性差异 [3] - 未来股息支付需经公司董事会批准 并满足债务协议和优先股条款的约定 [2] 公司投资策略与业务 - 公司为在纽交所上市的非多元化封闭式管理投资公司 [4] - 投资目标为提供高税后总回报 重点向股东进行现金分配 [4] - 公司计划将至少80%的总资产投资于能源基础设施公司证券 [4] 股息政策说明 - 公司向普通股股东支付的现金股息比率可能不时调整 [5] - 股息金额不保证 可能因投资组合持仓和市场条件等多种因素而变化 [5]